跳至主要内容
临床试验/NCT04315103
NCT04315103已完成2 期

Efficacy of a Single Crosslinked Hyaluronan (HYAJOINT Plus) Combined With a Single Platelet-rich Plasma (PRP) Versus a Single PRP for the Treatment of Knee Osteoarthritis: A Randomized-Controlled Trial

Kaohsiung Veterans General Hospital.4 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2018年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
85
试验地点
4
主要终点
VAS pain score change from baseline

研究概览

简要总结

Intraarticular hyaluronan or platelet-rich plasma (PRP) is each effective in the treatment for knee osteoarthritis (OA). The efficacy of combined hyaluronan with PRP for knee OA remained unclear. This study aimed to investigate the efficacy of a single intraarticular hyaluronan (HYAJOINT Plus) combined with a single PRP versus a single intraarticular PRP in patients with knee OA.

详细描述

Intraarticular HA or PRP has been used for knee OA for years. Combined HA and PRP has not been widely used for OA because of lack of clinical evidence. Based on in vitro and animal studies, combining HA and PRP may benefit from their dissimilar biological mechanisms for tissue repair and have potentials to synergistically promote cartilage regeneration, inhibit OA inflammation, modulate the disease process, and improve joint homeostasis in OA. Combination of HA and PRP has much potential for the treatment of OA, but the clinical evidence of this combination remains unclear. The purpose of this study was to investigate the efficacy and safety of combined a single crosslinked HA (HYAJOINT Plus) with a single PRP versus a single PRP alone in patients with knee OA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Study blinding was accomplished by having an investigator (blinded to the randomization and treatment) perform all the assessments

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 20-75 years;Symptomatic knee OA > 6 months despite conservative treatment such as oral analgesics, NSAIDs and/or physical therapy;Kellgren-Lawrence grades 2 knee OA on radiographs taken within the previous 6 months;Average pain at walking > 30 mm on a 100-mm visual analog scale (VAS);Radiological evidence of bilateral knee OA was accepted if global pain VAS in the contralateral knee< 30 mm.

排除标准

  • Previous orthopedic surgery on the spine or lower limbs Disabling OA of either hip or foot Knee instability, apparent joint effusion or marked valgus/varus deformity Known allergy to hyaluronan products Women ascertained or suspected pregnancy or lactating Intraarticular injections into the knee in the past 6 months Any specific medical conditions (rheumatoid arthritis, active infections, severe cardiovascular diseases, autoimmune diseases, hemiparesis, neoplasm, etc.) that would interfere with the assessments

结局指标

主要结局

VAS pain score change from baseline

时间窗: 1,3 and 6 months

. The patient rated the average severity of knee pain on knee movement over the previous week on a 0-100 mm VAS (0=no pain to 100=worst possible pain)

次要结局

  • The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC, Likert Scale)(1,3 and 6 months)
  • Single-leg stance test (SLS)(1,3 and 6 months)
  • satisfaction(1,3 and 6 months)
  • consumption of analgesics(1,3 and 6 months)
  • Lequesne index(1,3 and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shu-Fen Sun

Director or Neurorehabilitation

Kaohsiung Veterans General Hospital.

研究点 (4)

Loading locations...

相似试验